Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

In this Healio Video Perspective, Dante J. Pieramici, MD, discusses a trial investigating contrast sensitivity as a visual ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

ALEX TORDOFF is relishing the prospect of fulfilling a lifelong dream as he saddles up for his Defender Burghley Horse Trials debut.

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

HBAR tests key support at $0.23 after a 3% pullback Friday, with resistance forming near $0.24. Bullish catalysts emerge as ...